Platform

WellTheory, a digital health company for autoimmune disease, announced on Tuesday that it has raised $14 million in Series A funding, which will help the company scale and advance its AI. Atherton, California-based WellTheory treats autoimmune conditions such as Addison’s disease, celiac disease, multiple sclerosis and lupus. Using a collaborative care model, it partners with…